当前位置: X-MOL 学术 › International Journal of Antimicrobial Agents › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Antiviral activity of arbidol hydrochloride against herpes simplex virus I in vitro and in vivo.
International Journal of Antimicrobial Agents Pub Date : 2017-09-12 , DOI: 10.1016/j.ijantimicag.2017.09.001
Min-Ke Li 1 , Yuan-Yuan Liu 2 , Fei Wei 2 , Meng-Xin Shen 2 , Yan Zhong 2 , Shan Li 2 , Liang-Jun Chen 2 , Nian Ma 2 , Bing-Yu Liu 2 , Yi-Dong Mao 2 , Ning Li 2 , Wei Hou 2 , Hai-Rong Xiong 2 , Zhan-Qiu Yang 2
Affiliation  

Herpes simplex virus type 1 (HSV-1) causes significant human diseases ranging from skin lesions to encephalitis, especially in neonates and immunocompromised hosts. The discovery of novel anti-HSV-1 drugs with low toxicity is required for public health. Arbidol hydrochloride (ARB) is an indole derivative molecule with broad-spectrum antiviral activity. In this study, the antiviral effects of ARB against HSV-1 infection were evaluated in vitro and in vivo. The results showed that ARB presents significant inhibitory effect on HSV-1 plaque formation and generation of progeny virus, with EC50 values (50% effective concentration) of 5.39 µg/mL (10.49 µM) and 2.26 µg/mL (4.40 µM), respectively. Moreover, time-of-addition and time-of-removal assays further suggested that ARB has viral inhibitory effects when added up to 12 h post-infection (p.i.), which could be further corroborated by determining the expression of viral immediate-early (ICP4, ICP22 and ICP27), early (ICP8 and UL42) and late (gB, gD, gH, VP1/2 and VP16) genes by real-time quantitative PCR as well as the expression of viral protein ICP4 and ICP8 at 6 h and 12 h p.i. Results of the in vivo study showed that ARB could reduce guinea pig skin lesions caused by HSV-1 infection. Conclusively, this report offers new perspectives in the search for therapeutic measures in the treatment of HSV-1 infection.

中文翻译:

盐酸阿比多尔在体外和体内对单纯性疱疹病毒I的抗病毒活性。

1型单纯疱疹病毒(HSV-1)引起严重的人类疾病,从皮肤损害到脑炎,尤其是在新生儿和免疫功能低下的宿主中。公共卫生需要发现低毒性的新型抗HSV-1药物。盐酸阿比多尔(ARB)是具有广谱抗病毒活性的吲哚衍生物分子。在这项研究中,在体外和体内评估了ARB对HSV-1感染的抗病毒作用。结果表明,ARB对HSV-1斑块形成和子代病毒的产生具有明显的抑制作用,EC50值(50%有效浓度)分别为5.39 µg / mL(10.49 µM)和2.26 µg / mL(4.40 µM)。 。此外,添加时间和去除时间分析进一步表明,在感染后(pi)最多添加12 h时,ARB具有病毒抑制作用,通过实时定量PCR测定病毒的早期(ICP4,ICP22和ICP27),早期(ICP8和UL42)和晚期(gB,gD,gH,VP1 / 2和VP16)基因的表达可以进一步证实以及在感染后6 h和12 h病毒蛋白ICP4和ICP8的表达体内研究结果表明ARB可以减轻HSV-1感染引起的豚鼠皮肤损伤。总之,本报告为寻找HSV-1感染的治疗方法提供了新的见解。体内研究结果表明,ARB可以减轻HSV-1感染引起的豚鼠皮肤损伤。总之,本报告为寻找HSV-1感染的治疗方法提供了新的见解。体内研究结果表明,ARB可以减轻HSV-1感染引起的豚鼠皮肤损伤。总之,本报告为寻找HSV-1感染的治疗方法提供了新的见解。
更新日期:2019-11-01
down
wechat
bug